Advertisement
Screener

Rosetta Genomics Ltd. Proceeds from Warrant Exercises

Rosetta Genomics Ltd. Proceeds from Warrant Exercises

Rosetta Genomics Ltd. reported Proceeds from Warrant Exercises of $1.49 million for the 6-month period ending 2012-06-30, per its 6-K filed 2013-09-09.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromWarrantExercises · last filed 2013-09-09

  • 2012-06-30: Proceeds from Warrant Exercises 6 month $1.49M.
Period endProceeds from Warrant Exercises 6 month
2012-06-30$1.49M
6-K · filed 2013-09-09